Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant

Ankyrin repeat domain-containing protein 26- (ANKRD26-) related thrombocytopenia is a rare, autosomal dominant condition caused by ANKRD26 gene mutation. ANKRD26-related thrombocytopenia is characterized by moderate thrombocytopenia with minimal bleeding, normal platelet size, and dysmegakaryopoiesi...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Husnain, Trent Wang, Maikel Valdes, James Hoffman, Lazaros Lekakis
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/9357572
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562691268411392
author Muhammad Husnain
Trent Wang
Maikel Valdes
James Hoffman
Lazaros Lekakis
author_facet Muhammad Husnain
Trent Wang
Maikel Valdes
James Hoffman
Lazaros Lekakis
author_sort Muhammad Husnain
collection DOAJ
description Ankyrin repeat domain-containing protein 26- (ANKRD26-) related thrombocytopenia is a rare, autosomal dominant condition caused by ANKRD26 gene mutation. ANKRD26-related thrombocytopenia is characterized by moderate thrombocytopenia with minimal bleeding, normal platelet size, and dysmegakaryopoiesis on bone marrow evaluation. ANKRD26 mutation has been previously associated with myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia. We report the first case of multiple myeloma in a patient with ANKRD26 related thrombocytopenia. The patient was successfully treated with contemporary combination therapy followed by melphalan-conditioned autologous stem cell transplant for his multiple myeloma despite preexisting thrombocytopenia.
format Article
id doaj-art-a1eaacfbc3f54da19c34065b57caddd4
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-a1eaacfbc3f54da19c34065b57caddd42025-02-03T01:22:02ZengWileyCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/93575729357572Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell TransplantMuhammad Husnain0Trent Wang1Maikel Valdes2James Hoffman3Lazaros Lekakis4Division of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USADivision of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USASylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USADivision of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USADivision of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USAAnkyrin repeat domain-containing protein 26- (ANKRD26-) related thrombocytopenia is a rare, autosomal dominant condition caused by ANKRD26 gene mutation. ANKRD26-related thrombocytopenia is characterized by moderate thrombocytopenia with minimal bleeding, normal platelet size, and dysmegakaryopoiesis on bone marrow evaluation. ANKRD26 mutation has been previously associated with myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia. We report the first case of multiple myeloma in a patient with ANKRD26 related thrombocytopenia. The patient was successfully treated with contemporary combination therapy followed by melphalan-conditioned autologous stem cell transplant for his multiple myeloma despite preexisting thrombocytopenia.http://dx.doi.org/10.1155/2019/9357572
spellingShingle Muhammad Husnain
Trent Wang
Maikel Valdes
James Hoffman
Lazaros Lekakis
Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
Case Reports in Hematology
title Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
title_full Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
title_fullStr Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
title_full_unstemmed Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
title_short Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination Therapy and Autologous Stem Cell Transplant
title_sort multiple myeloma in a patient with ankrd26 related thrombocytopenia successfully treated with combination therapy and autologous stem cell transplant
url http://dx.doi.org/10.1155/2019/9357572
work_keys_str_mv AT muhammadhusnain multiplemyelomainapatientwithankrd26relatedthrombocytopeniasuccessfullytreatedwithcombinationtherapyandautologousstemcelltransplant
AT trentwang multiplemyelomainapatientwithankrd26relatedthrombocytopeniasuccessfullytreatedwithcombinationtherapyandautologousstemcelltransplant
AT maikelvaldes multiplemyelomainapatientwithankrd26relatedthrombocytopeniasuccessfullytreatedwithcombinationtherapyandautologousstemcelltransplant
AT jameshoffman multiplemyelomainapatientwithankrd26relatedthrombocytopeniasuccessfullytreatedwithcombinationtherapyandautologousstemcelltransplant
AT lazaroslekakis multiplemyelomainapatientwithankrd26relatedthrombocytopeniasuccessfullytreatedwithcombinationtherapyandautologousstemcelltransplant